本页面由Tiger Trade Technology Pte. Ltd.提供服务

Emergent Biosolutions

7.02
+0.27004.00%
盘前7.020.00000.00%04:16 EDT
成交量:137.86万
成交额:956.64万
市值:3.60亿
市盈率:-2.07
高:7.05
开:6.84
低:6.80
收:6.75
52周最高:14.06
52周最低:4.36
股本:5,127.33万
流通股本:4,837.27万
量比:0.98
换手率:2.85%
股息:- -
股息率:- -
每股收益(TTM):-3.3870
每股收益(LYR):0.9300
净资产收益率:-40.29%
总资产收益率:6.93%
市净率:1.05
市盈率(LYR):7.55

数据加载中...

2026/09/15

重要事件披露

Form 8-K - Current report
2026/09/02

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/31

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/29

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/29

重要事件披露

Form 8-K - Current report
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/10

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors